These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 25150317)

  • 1. Changes in urine autofluorescence in ovarian cancer patients.
    Birkova A; Gresova A; Steffekova Z; Kraus V; Ostro A; Toth R; Marekova M
    Neoplasma; 2014; 61(6):724-31. PubMed ID: 25150317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence characteristics of human urine from normal individuals and ovarian cancer patients.
    Zvarik M; Martinicky D; Hunakova L; Lajdova I; Sikurova L
    Neoplasma; 2013; 60(5):533-7. PubMed ID: 23790172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parallel factor analysis of ovarian autofluorescence as a cancer diagnostic.
    George R; Michaelides M; Brewer MA; Utzinger U
    Lasers Surg Med; 2012 Apr; 44(4):282-95. PubMed ID: 22407572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive autofluorescence of urine samples from individuals with bacteriuria compared with normals.
    Anwer AG; Sandeep PM; Goldys EM; Vemulpad S
    Clin Chim Acta; 2009 Mar; 401(1-2):73-5. PubMed ID: 19087871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine.
    Ye B; Skates S; Mok SC; Horick NK; Rosenberg HF; Vitonis A; Edwards D; Sluss P; Han WK; Berkowitz RS; Cramer DW
    Clin Cancer Res; 2006 Jan; 12(2):432-41. PubMed ID: 16428483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of surgical margins in oral cancer using in situ fluorescence spectroscopy.
    Francisco AL; Correr WR; Pinto CA; Gonçalves Filho J; Chulam TC; Kurachi C; Kowalski LP
    Oral Oncol; 2014 Jun; 50(6):593-9. PubMed ID: 24630901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic markers for early detection of ovarian cancer.
    Visintin I; Feng Z; Longton G; Ward DC; Alvero AB; Lai Y; Tenthorey J; Leiser A; Flores-Saaib R; Yu H; Azori M; Rutherford T; Schwartz PE; Mor G
    Clin Cancer Res; 2008 Feb; 14(4):1065-72. PubMed ID: 18258665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGF/TGF-alpha and progesterone in urine of ovarian cancer patients.
    Ridderheim M; Cajander S; Tavelin B; Stendahl U; Bäckström T
    Anticancer Res; 1994; 14(5B):2119-23. PubMed ID: 7840510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
    Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laser-induced autofluorescence microscopy of normal and tumor human colonic tissue.
    Huang Z; Zheng W; Xie S; Chen R; Zeng H; McLean DI; Lui H
    Int J Oncol; 2004 Jan; 24(1):59-63. PubMed ID: 14654941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence.
    Havrilesky LJ; Whitehead CM; Rubatt JM; Cheek RL; Groelke J; He Q; Malinowski DP; Fischer TJ; Berchuck A
    Gynecol Oncol; 2008 Sep; 110(3):374-82. PubMed ID: 18584856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fourier-transform infrared spectroscopy coupled with a classification machine for the analysis of blood plasma or serum: a novel diagnostic approach for ovarian cancer.
    Gajjar K; Trevisan J; Owens G; Keating PJ; Wood NJ; Stringfellow HF; Martin-Hirsch PL; Martin FL
    Analyst; 2013 Jul; 138(14):3917-26. PubMed ID: 23325355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of the Stockholm screening study on ovarian cancer.
    Einhorn N; Bast R; Knapp R; Nilsson B; Zurawski V; Sjövall K
    Gynecol Oncol; 2000 Dec; 79(3):466-70. PubMed ID: 11104621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of mid-infrared spectroscopy as a non-invasive diagnostic test in urine for endometrial or ovarian cancer.
    Paraskevaidi M; Morais CLM; Lima KMG; Ashton KM; Stringfellow HF; Martin-Hirsch PL; Martin FL
    Analyst; 2018 Jun; 143(13):3156-3163. PubMed ID: 29878018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of serum biomarkers for detection of early-stage ovarian cancer.
    Nosov V; Su F; Amneus M; Birrer M; Robins T; Kotlerman J; Reddy S; Farias-Eisner R
    Am J Obstet Gynecol; 2009 Jun; 200(6):639.e1-5. PubMed ID: 19285648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology.
    Petri AL; Simonsen AH; Yip TT; Hogdall E; Fung ET; Lundvall L; Hogdall C
    Acta Obstet Gynecol Scand; 2009; 88(1):18-26. PubMed ID: 19023702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine metabolite analysis offers potential early diagnosis of ovarian and breast cancers.
    Slupsky CM; Steed H; Wells TH; Dabbs K; Schepansky A; Capstick V; Faught W; Sawyer MB
    Clin Cancer Res; 2010 Dec; 16(23):5835-41. PubMed ID: 20956617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of isotope-coded protein labeling for prioritization of proteins found in ovarian cancer patient urine.
    Rainczuk A; Condina M; Pelzing M; Dolman S; Rao J; Fairweather N; Jobling T; Stephens AN
    J Proteome Res; 2013 Sep; 12(9):4074-88. PubMed ID: 23952987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fundus spectrometry in age-related maculopathy].
    Schweitzer D; Beuermann B; Hammer M; Schweitzer F; Richter S; Leistritz L; Scibor M; Thamm E; Kolb A; Anders R
    Klin Monbl Augenheilkd; 2005 May; 222(5):396-408. PubMed ID: 15912457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer.
    Yousef GM; Polymeris ME; Grass L; Soosaipillai A; Chan PC; Scorilas A; Borgoño C; Harbeck N; Schmalfeldt B; Dorn J; Schmitt M; Diamandis EP
    Cancer Res; 2003 Jul; 63(14):3958-65. PubMed ID: 12873991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.